Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction
Author(s) -
Jay H. Traverse,
Timothy D. Henry,
Carl J. Pepine,
James T. Willerson,
David Zhao,
Stephen G. Ellis,
John R. Forder,
R. David Anderson,
Antonis K. Hatzopoulos,
Marc S. Penn,
Emerson C. Perin,
Jeffrey Chambers,
Kenneth W. Baran,
Ganesh Raveendran,
Charles Lambert,
Amir Lerman,
Daniel I. Simon,
Douglas E. Vaughan,
Dejian Lai,
Adrian P. Gee,
Doris A. Taylor,
Christopher R. Cogle,
James D. Thomas,
Rachel Olson,
Sherry Bowman,
Judy Francescon,
Carrie Geither,
Eileen Handberg,
Casey Kappenman,
Lynette Westbrook,
Linda B. Piller,
Lara M. Simpson,
Sarah Baraniuk,
Cătălin Loghin,
David Aguilar,
Sara Richman,
Claudia Zierold,
Daniel B. Spoon,
Judy Bettencourt,
Shelly L. Sayre,
Rachel W. Vojvodic,
Sonia I. Skarlatos,
David J. Gordon,
Ray F. Ebert,
Minjung Kwak,
Lemuel A. Moyé,
Robert D. Simari
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2012.28726
Subject(s) - medicine , ejection fraction , myocardial infarction , cardiology , conventional pci , percutaneous coronary intervention , heart failure , ventricular remodeling , cardiac function curve
While the delivery of cell therapy after ST-segment elevation myocardial infarction (STEMI) has been evaluated in previous clinical trials, the influence of the timing of cell delivery on the effect on left ventricular function has not been analyzed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom